Long-term outcomes following acute kidney injury in individuals with pre-existing chronic kidney disease: a systematic review and meta-analysis.

IF 2.6 4区 医学 Q2 UROLOGY & NEPHROLOGY
Xingmu Wang, Jianling He, Yaoqin Wang
{"title":"Long-term outcomes following acute kidney injury in individuals with pre-existing chronic kidney disease: a systematic review and meta-analysis.","authors":"Xingmu Wang, Jianling He, Yaoqin Wang","doi":"10.1007/s40620-025-02373-8","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Acute kidney injury (AKI) is linked to a heightened risk of progressing to chronic kidney disease (CKD) in individuals exhibiting normal baseline kidney function. However, the extent of such association in individuals with pre-existing CKD or renal impairment has been insufficiently investigated. Hence, we performed an extensive literature review and meta-analysis of the literature.</p><p><strong>Methods: </strong>Articles published on PubMed, Embase, and Cochrane (up to December 2, 2024) were searched for post-hoc analyses/sub-analysis of randomized controlled trials (RCTs) or observational studies that evaluated the association between AKI insult and long-term progression or overall death in individuals with pre-existing CKD or kidney dysfunction. All selected articles incorporated odds ratio (OR), hazard ratio (HR), or relative risk (RR) statistics along with data for assessing the association. Pooled RRs and 95% confidence intervals (CI) were derived utilizing random-effects models, notwithstanding the heterogeneity evaluated by I<sup>2</sup> statistic. The protocol was not registered at PROSPERO or SRDR.</p><p><strong>Results: </strong>Ultimately, 39 studies with an aggregate of 332,198 participants were determined to be eligible for inclusion. Of them, 28 studies were included in an analysis of CKD progression risk, and 27 studies were incorporated in the analysis of all-cause mortality. Individuals who have experienced AKI were at  elevated risk for progression of CKD (HR 2.36, 95% CI 1.96-2.85) and all-cause mortality (1.58, 1.38-1.81) with significant heterogeneity. Subgroup and sensitivity analyses supported the findings. For both outcomes, gradient of risk was observed as the AKI stage increased. For all-cause mortality, the risk magnitude was modified by the clinical environment.</p><p><strong>Conclusions: </strong>A history of AKI is correlated with heightened risks of CKD progression and overall death in patients with pre-existing CKD. Future research should be focused on the frequency of AKI episodes, the restoration of kidney function according to the different timeframe, and the impact of concomitant proteinuria on prognosis in these patients.</p>","PeriodicalId":16542,"journal":{"name":"Journal of Nephrology","volume":" ","pages":""},"PeriodicalIF":2.6000,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Nephrology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s40620-025-02373-8","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"UROLOGY & NEPHROLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Acute kidney injury (AKI) is linked to a heightened risk of progressing to chronic kidney disease (CKD) in individuals exhibiting normal baseline kidney function. However, the extent of such association in individuals with pre-existing CKD or renal impairment has been insufficiently investigated. Hence, we performed an extensive literature review and meta-analysis of the literature.

Methods: Articles published on PubMed, Embase, and Cochrane (up to December 2, 2024) were searched for post-hoc analyses/sub-analysis of randomized controlled trials (RCTs) or observational studies that evaluated the association between AKI insult and long-term progression or overall death in individuals with pre-existing CKD or kidney dysfunction. All selected articles incorporated odds ratio (OR), hazard ratio (HR), or relative risk (RR) statistics along with data for assessing the association. Pooled RRs and 95% confidence intervals (CI) were derived utilizing random-effects models, notwithstanding the heterogeneity evaluated by I2 statistic. The protocol was not registered at PROSPERO or SRDR.

Results: Ultimately, 39 studies with an aggregate of 332,198 participants were determined to be eligible for inclusion. Of them, 28 studies were included in an analysis of CKD progression risk, and 27 studies were incorporated in the analysis of all-cause mortality. Individuals who have experienced AKI were at  elevated risk for progression of CKD (HR 2.36, 95% CI 1.96-2.85) and all-cause mortality (1.58, 1.38-1.81) with significant heterogeneity. Subgroup and sensitivity analyses supported the findings. For both outcomes, gradient of risk was observed as the AKI stage increased. For all-cause mortality, the risk magnitude was modified by the clinical environment.

Conclusions: A history of AKI is correlated with heightened risks of CKD progression and overall death in patients with pre-existing CKD. Future research should be focused on the frequency of AKI episodes, the restoration of kidney function according to the different timeframe, and the impact of concomitant proteinuria on prognosis in these patients.

慢性肾脏疾病患者急性肾损伤后的长期预后:一项系统回顾和荟萃分析
背景:在基线肾功能正常的个体中,急性肾损伤(AKI)与进展为慢性肾脏疾病(CKD)的风险增加有关。然而,在已有CKD或肾脏损害的个体中,这种关联的程度尚未得到充分的研究。因此,我们进行了广泛的文献综述和文献荟萃分析。方法:检索发表在PubMed、Embase和Cochrane(截止到2024年12月2日)上的文章,对随机对照试验(rct)或观察性研究进行事后分析/亚分析,以评估先前存在CKD或肾功能不全的患者AKI损伤与长期进展或总体死亡之间的关系。所有入选的文章都纳入了优势比(OR)、风险比(HR)或相对风险(RR)统计数据以及评估相关性的数据。尽管采用I2统计量评估异质性,但仍利用随机效应模型推导出合并rr和95%置信区间(CI)。该协议未在PROSPERO或SRDR注册。结果:最终,39项研究共332,198名受试者被确定为符合纳入条件。其中,28项研究纳入CKD进展风险分析,27项研究纳入全因死亡率分析。经历过AKI的个体CKD进展的风险升高(HR 2.36, 95% CI 1.96-2.85),全因死亡率(1.58,1.38-1.81)具有显著的异质性。亚组分析和敏感性分析支持这一发现。对于这两个结果,随着AKI分期的增加,观察到风险梯度。对于全因死亡率,风险大小随临床环境而改变。结论:AKI病史与已有CKD患者CKD进展和总体死亡风险增加相关。未来的研究重点应放在AKI发作的频率、不同时间段的肾功能恢复情况以及合并蛋白尿对预后的影响等方面。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Journal of Nephrology
Journal of Nephrology 医学-泌尿学与肾脏学
CiteScore
5.60
自引率
5.90%
发文量
289
审稿时长
3-8 weeks
期刊介绍: Journal of Nephrology is a bimonthly journal that considers publication of peer reviewed original manuscripts dealing with both clinical and laboratory investigations of relevance to the broad fields of Nephrology, Dialysis and Transplantation. It is the Official Journal of the Italian Society of Nephrology (SIN).
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信